| pubmed-article:14583847 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14583847 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:14583847 | lifeskim:mentions | umls-concept:C0205466 | lld:lifeskim |
| pubmed-article:14583847 | lifeskim:mentions | umls-concept:C0030946 | lld:lifeskim |
| pubmed-article:14583847 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
| pubmed-article:14583847 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:14583847 | lifeskim:mentions | umls-concept:C0205470 | lld:lifeskim |
| pubmed-article:14583847 | lifeskim:mentions | umls-concept:C0449243 | lld:lifeskim |
| pubmed-article:14583847 | lifeskim:mentions | umls-concept:C0887947 | lld:lifeskim |
| pubmed-article:14583847 | lifeskim:mentions | umls-concept:C1707719 | lld:lifeskim |
| pubmed-article:14583847 | lifeskim:mentions | umls-concept:C0205265 | lld:lifeskim |
| pubmed-article:14583847 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:14583847 | lifeskim:mentions | umls-concept:C1555582 | lld:lifeskim |
| pubmed-article:14583847 | lifeskim:mentions | umls-concept:C0301625 | lld:lifeskim |
| pubmed-article:14583847 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:14583847 | pubmed:dateCreated | 2003-10-29 | lld:pubmed |
| pubmed-article:14583847 | pubmed:abstractText | To assess predictive factors of long-term immune restoration in patients who started protease inhibitor (PI)-based HAART and experienced virological rebound after initial complete success. | lld:pubmed |
| pubmed-article:14583847 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14583847 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14583847 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14583847 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14583847 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14583847 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14583847 | pubmed:issn | 1528-4336 | lld:pubmed |
| pubmed-article:14583847 | pubmed:author | pubmed-author:CarosiGG | lld:pubmed |
| pubmed-article:14583847 | pubmed:author | pubmed-author:CastelliFF | lld:pubmed |
| pubmed-article:14583847 | pubmed:author | pubmed-author:GargiuloFF | lld:pubmed |
| pubmed-article:14583847 | pubmed:author | pubmed-author:PatroneMM | lld:pubmed |
| pubmed-article:14583847 | pubmed:author | pubmed-author:TinelliCC | lld:pubmed |
| pubmed-article:14583847 | pubmed:author | pubmed-author:AiròPP | lld:pubmed |
| pubmed-article:14583847 | pubmed:author | pubmed-author:ParaninfoGG | lld:pubmed |
| pubmed-article:14583847 | pubmed:author | pubmed-author:TortiCC | lld:pubmed |
| pubmed-article:14583847 | pubmed:author | pubmed-author:Quiros-Roldan... | lld:pubmed |
| pubmed-article:14583847 | pubmed:author | pubmed-author:UccelliM CMC | lld:pubmed |
| pubmed-article:14583847 | pubmed:author | pubmed-author:TomasoniL RLR | lld:pubmed |
| pubmed-article:14583847 | pubmed:author | pubmed-author:Brescia-MASTE... | lld:pubmed |
| pubmed-article:14583847 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14583847 | pubmed:volume | 4 | lld:pubmed |
| pubmed-article:14583847 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14583847 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14583847 | pubmed:pagination | 311-23 | lld:pubmed |
| pubmed-article:14583847 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:meshHeading | pubmed-meshheading:14583847... | lld:pubmed |
| pubmed-article:14583847 | pubmed:articleTitle | Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switch. | lld:pubmed |
| pubmed-article:14583847 | pubmed:affiliation | Institute for Infectious and Tropical Diseases, University of Brescia, Italy. | lld:pubmed |
| pubmed-article:14583847 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14583847 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
